High Growth Tech Stocks To Watch In September 2024

The market has climbed by 3.0% over the past week, with every sector up, and is up 25% over the last 12 months, with earnings forecast to grow by 15% annually. In this thriving environment, identifying high growth tech stocks can be key to capitalizing on potential gains in September 2024.

Top 10 High Growth Tech Companies In The United States

Name	Revenue Growth	Earnings Growth	Growth Rating
TG Therapeutics	28.39%	43.54%	★★★★★★
Super Micro Computer	20.66%	27.13%	★★★★★★
Sarepta Therapeutics	23.58%	44.12%	★★★★★★
Invivyd	42.91%	70.39%	★★★★★★
Ardelyx	27.44%	65.92%	★★★★★★
G1 Therapeutics	27.57%	57.75%	★★★★★★
Amicus Therapeutics	20.32%	62.37%	★★★★★★
Travere Therapeutics	26.68%	68.80%	★★★★★★
Seagen	22.57%	71.80%	★★★★★★
ImmunoGen	26.00%	45.85%	★★★★★★

Click here to see the full list of 250 stocks from our US High Growth Tech and AI Stocks screener.

Let's explore several standout options from the results in the screener.

Autodesk (NasdaqGS:ADSK)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Autodesk, Inc. provides 3D design, engineering, and entertainment technology solutions worldwide and has a market cap of $57.57 billion.

Operations: Autodesk generates revenue primarily from its CAD/CAM software segment, which accounted for $5.81 billion. The company focuses on providing advanced technology solutions in design and engineering fields.

Autodesk's strategic partnership with Makersite enhances its sustainability and compliance capabilities, crucial for product design stages where 80% of environmental impact is determined. The company reported Q2 revenue of $1.51 billion, up from $1.35 billion a year ago, with net income rising to $282 million from $222 million. Autodesk has also repurchased 471,000 shares for $115.22 million between May and July 2024, reflecting confidence in its growth trajectory amidst a forecasted annual earnings increase of 16.7%.

• Delve into the full analysis health report here for a deeper understanding of Autodesk.

• Gain insights into Autodesk's historical performance by reviewing our past performance report.

Amgen (NasdaqGS:AMGN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Amgen Inc. is a global biotechnology company that focuses on discovering, developing, manufacturing, and delivering human therapeutics, with a market cap of approximately $180.14 billion.

Operations: Amgen generates revenue primarily through its human therapeutics segment, which accounted for $30.93 billion. The company's focus on biotechnology involves significant investment in R&D and manufacturing to support its product pipeline and market delivery.

Amgen's R&D expenditure, at $4.20 billion for the past year, underscores its commitment to innovation, particularly in oncology and molecularly targeted therapies. The company's revenue growth is forecasted at a modest 3% annually, while earnings are expected to surge by 23.8% per year. Despite a significant one-off gain of $1 billion impacting recent financials, Amgen's focus on high-potential segments like KRAS G12C-mutated NSCLC treatments positions it well for future advancements in biotech solutions.

• Unlock comprehensive insights into our analysis of Amgen stock in this health report.

• Gain insights into Amgen's past trends and performance with our Past report.

Wix.com (NasdaqGS:WIX)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Wix.com Ltd., with a market cap of $8.76 billion, operates as a cloud-based web development platform for registered users and creators worldwide.

Operations: Wix.com Ltd. generates revenue primarily from its internet software and services segment, amounting to $1.65 billion. The company offers a cloud-based platform enabling web development for users globally.

Wix.com, with an annual revenue growth forecast of 11.4%, is outpacing the US market's 8.7% growth rate, while its earnings are expected to surge by 32% annually. The company has recently become profitable and reported a net income of $63.52 million for the first half of 2024, compared to $23.21 million in the previous year. Notably, Wix spent $200 million on share repurchases in July 2024 and continues to innovate with AI-powered tools enhancing user content creation efficiency and customization capabilities on their platform.

• Dive into the specifics of Wix.com here with our thorough health report.

• Assess Wix.com's past performance with our detailed historical performance reports.

Next Steps

• Gain an insight into the universe of 250 US High Growth Tech and AI Stocks by clicking here.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com